Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
about
Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent DeliveryThe development of an AIDS mucosal vaccine.Direct injection of functional single-domain antibodies from E. coli into human cells.Improving Salmonella vector with rec mutation to stabilize the DNA cargoes.Mucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost.Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines.Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity.Trial watch: Naked and vectored DNA-based anticancer vaccinesSalmonella enterica serovar Typhi live vector vaccines finally come of ageAnthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.An oral recombinant Salmonella enterica serovar Typhimurium mutant elicits systemic antigen-specific CD8+ T cell cytokine responses in miceOral vaccine delivery: can it protect against non-mucosal pathogens?A one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine.Transgenic plant-based oral vaccines.Delivery of functional DNA and messenger RNA to mammalian phagocytic cells by recombinant yeast.Salmonella Vaccines: Conduits for Protective Antigens.
P2860
Q28084076-E7CA5CA9-5AA9-4A0B-9959-87C3DC8A3698Q30408103-97B3D8CD-090E-4AD3-B7D2-2449BE44E669Q33775617-134CB48B-A1DC-4115-9C56-D7E53AA3285EQ33814907-72349ABA-4CD3-403E-B3F0-5E7C41312DF4Q33824782-7515975C-201F-4239-8BBE-1A2AB7831BFBQ34529634-F82A4754-7579-42ED-B8EF-59F3CFC34048Q35059006-29FCD808-46C1-4B87-A109-25D8BCEF29D0Q35798986-B3B889A1-9472-4B8A-AE3C-41EA21DE3B7FQ37106127-56663C7E-2E5F-492A-97E7-F48B267E6D41Q37145004-079996F3-F7C4-4667-A681-2B767ED8AA37Q37185975-8FC37B46-4E86-437F-93AD-005FC1BE9BABQ37229915-975203CF-4F01-4ADF-93FA-0E354AAB74A3Q37333919-BC226127-CBDC-423E-9BBF-F8EB2B472BF5Q37744913-F7E2B330-F6CC-47CF-BFDA-46E196F0B87CQ39484819-82D0FF46-E0ED-41EF-A631-58BE5DD7233FQ49644946-996F3958-5715-4608-A2A1-F348B8D0722E
P2860
Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Live-attenuated Salmonella as ...... s in humans: are we there yet?
@en
type
label
Live-attenuated Salmonella as ...... s in humans: are we there yet?
@en
prefLabel
Live-attenuated Salmonella as ...... s in humans: are we there yet?
@en
P2860
P356
P1476
Live-attenuated Salmonella as ...... s in humans: are we there yet?
@en
P2093
George K Lewis
P2860
P304
P356
10.1586/14760584.6.3.431
P577
2007-06-01T00:00:00Z